Andere Sprachen ImpediMed Limited

Aktien

Verzögert Australian S.E. Andere Börsenplätze 08:10:52 24.04.2024			% 5 Tage	% 1. Jan.
0.09 ^AUD	0.00%		-4.26%	-37.93%

17.04.	IMPEDIMED LIMITED : Bewertung von Ord Minnet kaufen	ZM
11.04.	ImpediMed präsentiert Ergebnisse einer Studie zu chronischen Lymphödemen bei Brustkrebs auf der Jahrestagung der American Society of Breast Surgeons	CI

Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	17.04.
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	11.04.
ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index	18.03.
Impedimed Names Independent Non-Executive Chair	27.02.
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	27.02.
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26.02.
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	14.02.
ImpediMed CEO, CFO Step Down; Shares Fall 11%	20.11.
ImpediMed Limited Announces CEO Changes	19.11.
ImpediMed Limited Announces CFO Changes	19.11.
ImpediMed Limited Announces Management Changes	19.11.
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	03.11.
Morgans rates IPD as Add	01.11.
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03.10.23
Impedimed Limited Announces Board Changes	28.09.23
Declaration of Voting Results by ImpediMed Limited	28.09.23
ImpediMed Appoints Medical Chief; Shares Down 3%	27.09.23
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	27.09.23
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	31.08.23
ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31.08.23

Keine Ergebnisse zu dieser Suche